News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis B
Demand for Hepatitis B Vaccines to Soar from End-use Industries and Push Revenues in the Global Market

The global market for hepatitis B vaccine is growing at a significant rate due to increasing number of cases with hepatitis B infection. In addition, growing population and growing awareness for improved healthcare facilities is increasing the global market for hepatitis B vaccine.

Published
02 April 2019
From
New Daily Herald
Elimination of hepatitis C
San Francisco Study Shows Engagement in HCV Care Aids Elimination

In San Francisco, many transwomen have access to hepatitis C virus (HCV) testing and treatment, which suggests an opportunity for HCV control and elimination, according to a study recently published in the Journal of Viral Hepatitis.

Published
02 April 2019
From
Infectious Disease Advisor
Access to medicines and treatment
EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards

This is the full report from the EACS Standard of Care Meeting. It can also be read in three separate sections here.Eastern Europe continues to have

Published
29 March 2019
By
Gus Cairns
Hepatitis C transmission and prevention
Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men

Incidence of acute hepatitis C virus (HCV) among men who have sex with men (MSM) who use pre-exposure prophylaxis (PrEP) in Lyon increased tenfold between

Published
29 March 2019
By
Michael Carter
Hepatitis C treatment
Louisiana picks drug company for hepatitis C treatment plan

Gilead Sciences subsidiary Asegua Therapeutics LLC won the contract, selected from three companies that sought to partner with the state. Louisiana will pay a fee to the drug manufacturer for unlimited access to its hepatitis C medication, a generic version of Epclusa, for five years.

Published
27 March 2019
From
San Francisco Chronicle
Hepatitis and HIV
Hepatic steatosis common in young adults with life-long HIV

Thirty-three percent of young adults with HIV since birth or early childhood have hepatic steatosis, a prevalence comparable to older adults with HIV and “significantly higher” than HIV-negative controls, according to research published in The Journal of Infectious Diseases

Published
26 March 2019
From
Healio
Hepatitis B
Hepatitis B Virus Elevates Risk for Age-Related Macular Degeneration

Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration (AMD), according to a new report. It’s possible that hepatitis B virus may even accelerate the progression of AMD.

Published
14 March 2019
From
MD Magazine
People who inject drugs
Dramatic rise in U.S. opioid deaths as epidemic spreads to eastern states

Long believed to be concentrated among Appalachian states and parts of the Midwest, Alexander's research shows that the crisis has spread. Eastern states have seen a sharp rise in opioid deaths – with Connecticut, Illinois, Indiana, Massachusetts, Maryland, Maine, New Hampshire and Ohio among the states with the highest rise in opioid-related deaths.

Published
13 March 2019
From
Medical Xpress
Cancer
Higher HIV viral load and lower CD4 count linked to liver cancer risk

People living with HIV who have a longer duration of detectable viral load and those with low CD4 cell counts have a higher likelihood of developing liver

Published
13 March 2019
By
Liz Highleyman
Hepatitis B
Sixfold increased risk of infant HIV infection and high rates of low birth weight among women with HIV/hepatitis B co-infection

Women with high levels of hepatitis B viraemia (>106IU/ml) who have co-infection with HIV had a more than sixfold increased risk of having infants with HIV infection

Published
12 March 2019
By
Carole Leach-Lemens
← Prev12345...246Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.